Kynam Capital Management, LP Caribou Biosciences, Inc. Transaction History
Kynam Capital Management, LP
- $1.22 Billion
- Q3 2024
A detailed history of Kynam Capital Management, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,356,147 shares of CRBU stock, worth $5.18 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,356,147
Previous 1,646,702
43.08%
Holding current value
$5.18 Million
Previous $2.7 Million
70.15%
% of portfolio
0.38%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding CRBU
# of Institutions
142Shares Held
52.1MCall Options Held
37.4KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$10.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$10.1 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$8.98 Million0.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.34MShares$5.16 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $134M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...